Access to New Drugs: Moving Forward with Speed and Safety
EDITOR’S NOTE: THIS PIECE IS AUTHORED BY COURTNEY STORM. AN AUTHOR OF PEER-VIEWED PUBLICATIONS ON TOPICS RANGING FROM FINANCIAL CONFLICTS ...
Read moreDetailsEDITOR’S NOTE: THIS PIECE IS AUTHORED BY COURTNEY STORM. AN AUTHOR OF PEER-VIEWED PUBLICATIONS ON TOPICS RANGING FROM FINANCIAL CONFLICTS ...
Read moreDetailsEDITOR’S NOTE: THIS PIECE IS AUTHORED BY Ellen Agler, CEO of the END Fund. This piece is a republication, originally ...
Read moreDetails
Impakter keeps you informed through its ESG news platform and empowers your business through the Impakter Index.
To assess and improve your company’s ESG performance, explore Klimado’s ESG dashboard and assessment tools at www.klimado.com.
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2026 IMPAKTER. All rights reserved.